ReWalk Robotics Ltd. (NASDAQ:LFWD) Sees Large Decrease in Short Interest

ReWalk Robotics Ltd. (NASDAQ:LFWD) was the recipient of a significant decline in short interest in October. As of October 15th, there was short interest totalling 188,100 shares, a decline of 5.9% from the September 30th total of 199,800 shares. Based on an average daily trading volume, of 36,800 shares, the short-interest ratio is presently 5.1 days. Approximately 2.7% of the shares of the stock are short sold.

Institutional Trading of ReWalk Robotics

A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP bought a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned 0.16% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission. 26.76% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their price objective on shares of ReWalk Robotics from $9.00 to $13.00 and gave the stock a “buy” rating in a report on Friday, August 16th.

ReWalk Robotics Stock Performance

ReWalk Robotics stock opened at $2.31 on Thursday. The business’s fifty day moving average is $3.02 and its two-hundred day moving average is $3.88. The firm has a market cap of $19.87 million, a P/E ratio of -0.74 and a beta of 2.02. ReWalk Robotics has a 52 week low of $2.23 and a 52 week high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings results on Thursday, August 15th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.53) by $0.03. The business had revenue of $6.71 million for the quarter, compared to the consensus estimate of $6.71 million. ReWalk Robotics had a negative net margin of 102.03% and a negative return on equity of 41.89%. During the same quarter in the prior year, the company earned ($0.35) EPS. On average, equities research analysts predict that ReWalk Robotics will post -1.65 earnings per share for the current year.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.